MUVON Therapeutics AG

MUVON enables healthy ageing! We reverse age- or damage-related disability for functional skeletal muscle regeneration. Our cell-based regenerative platform technology allows for successful muscle restoration, using very low-risk, minimally-invasive treatment modalities, bringing personalized medicine to the patients in need. With our first pipeline indication, we successfully completed a PhaseI clinical trial, resulting in functional restoration of the sphincter muscle of patients, suffering from the highly-debilitating disease, called stress urinary incontinence, affecting 40%of women over 40 and 20% of men over 60. Now we running a Phase 2 clinical trial and are looking for your support to bring the therapy to all patients.